Duarte Lobo, Diana
Nobre, Rui Jorge
Oliveira Miranda, Catarina
Pereira, Dina
Castelhano, João
Sereno, José
Koeppen, Arnulf
Castelo-Branco, Miguel
Pereira de Almeida, Luís https://orcid.org/0000-0001-5831-3307
Funding for this research was provided by:
COMPETE 2020 (BrainHealth2020 projects (CENTRO-01-0145-FEDER-000008), ViraVector (CENTRO-01-0145-FEDER-022095), CortaCAGs (POCI-01-0145-FEDER-016719), SpreadSilencing POCI-01-0145-FEDER-029716, Imagene POCI-01-0145-FEDER-016807, CancelStem POCI-01-0145-FEDER-016390)
Compete2020 (UID4950/2020 (to MCB), BIN – National Brain Imaging Network (CENTRO-01-0145-FEDER-022118))
French Muscular Dystrophy Association (21163)
National Ataxia Foundation (-)
Richard Chin and Lily Lock Machado-Joseph Disease Research Fund (-)
Article History
Received: 11 April 2020
Accepted: 25 May 2020
First Online: 31 August 2020
Ethics approval and consent to participate
: All animal experiments were carried out in accordance with the European Community Council Directive (2010/63/EU) for the care and use of laboratory animals and previously approved by the Responsible Organization for the Animals Welfare of the Faculty of Medicine and Center for Neuroscience and Cell Biology of the University of Coimbra (ORBEA and FMUC/CNC, Coimbra, Portugal).Tissue from MJD patients and controls was obtained from the Neurology and Pathology Services, VA Medical Center, Albany Medical College, Albany, New York, NY, USA. All donors or their surrogates, had given informed consent for the use of their brain tissue for research purposes in accordance with the medical ethical committee of Albany Medical College, USA.
: Not applicable.
: The authors declare that they have no competing interests.